Noncanonical mechanism of Nrf2 activation by diacylglycerol polyethylene glycol adducts in normal human epidermal keratinocytes

PLoS One. 2023 Oct 11;18(10):e0291905. doi: 10.1371/journal.pone.0291905. eCollection 2023.

Abstract

Polyethylene glycol-23 glyceryl distearate (GDS-23), a diacylglycerol polyethylene glycol adduct, forms niosomes with a liposome-like structure and functions as an active ingredient in drug delivery systems. In addition, it upregulates antioxidant proteins such as heme oxygenase 1 and NAD(P)H-quinone dehydrogenase 1 in cells. However, the activation of nuclear factor E2-related factor-2 (Nrf2), which plays a role in inducing the expression of antioxidant proteins, and its protective effects induced by GDS-23 treatment against oxidative stress have not been elucidated. This study aimed at verifying the activation of Nrf2 by GDS-23 and clarifying its underlying mechanisms, and investigated whether GDS-23 protects against hydroquinone-induced cytotoxicity. Normal human epidermal keratinocytes were treated with GDS-23. Real-time reverse transcription-polymerase chain reaction, western blotting, and immunostaining were used to investigate the mechanism of Nrf2 activation, and neutral red assay was performed to evaluate cytotoxicity. GDS-23-treated cells showed an increase in antioxidant protein levels and stabilization of Nrf2 in the nucleus. During Nrf2 activation, p62, an autophagy-related adaptor protein, was phosphorylated at Ser349. Inhibition of the interaction between the phosphorylated p62 and Kelch-like ECH-associated protein 1 significantly suppressed the GDS-23-mediated induction of antioxidant protein expression. In addition, hydroquinone-induced cell toxicity was significantly attenuated by GDS-23. GDS-23 induced the intracellular antioxidant system by activating Nrf2 in a p62 phosphorylation-dependent manner without generating oxidative stress in the cells. GDS-23 may be applied as a multifunctional material for drug delivery system that enhances internal antioxidant systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants* / metabolism
  • Diglycerides / pharmacology
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism
  • Humans
  • Hydroquinones / toxicity
  • Kelch-Like ECH-Associated Protein 1 / metabolism
  • Keratinocytes / metabolism
  • NF-E2-Related Factor 2* / metabolism
  • Oxidative Stress
  • Polyethylene Glycols / metabolism
  • Polyethylene Glycols / pharmacology

Substances

  • Antioxidants
  • Diglycerides
  • Heme Oxygenase-1
  • hydroquinone
  • Hydroquinones
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • Polyethylene Glycols

Grants and funding

This study was funded by Beverly Glen Laboratories, Inc. https://www.bglen.com TM is an employee of Beverly Glen Laboratories, Inc. BCK is Chief Science Officer of Beverly Glen Laboratories, Inc. TM conceived the idea for this study, conducted the experiments, and wrote the paper. BCK contributed to analysis of the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.